Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 3/20 | 0.45 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.41 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 4/20 | 0.40 |
| ▸ | AMY2A | P04746 | 4/20 | 0.40 |
| ▸ | MGAM | O43451 | 2/20 | 0.40 |
| ▸ | AMY1A | P0DUB6 | 2/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | FGF1 | P05230 | 1/20 | 0.38 |
| ▸ | FGF2 | P09038 | 1/20 | 0.38 |
| ▸ | VEGFA | P15692 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL15229271 | 0.99 | LGALS8 (0.44) | LGALS8LGALS3LGALS4GAAAMY2A | |
| SCHEMBL15709358 | 0.88 | LGALS3 (0.46) | LGALS8LGALS3LGALS4GAAAMY2A | |
| SCHEMBL1816454 | 0.86 | LGALS8 (0.49) | LGALS8LGALS3LGALS4GAAAMY2A | |
| SCHEMBL2237219 | 0.85 | LGALS8 (0.49) | LGALS8LGALS3LGALS4GAAAMY2A | |
| SCHEMBL8468755 | 0.85 | LGALS8 (0.52) | LGALS8LGALS3LGALS4GAAAMY2A | |
| SCHEMBL12502058 | 0.85 | LGALS8 (0.48) | LGALS8LGALS3LGALS4GAAAMY2A | |
| SCHEMBL17767392 | 0.83 | LGALS8 (0.56) | LGALS8LGALS3LGALS4GAAAMY2A | |
| SCHEMBL5395795 | 0.82 | LGALS8 (0.49) | LGALS8LGALS3LGALS4GAAAMY2A | |
| Maltose SCHEMBL8994870 | 0.82 | LGALS8 (0.53) | LGALS8LGALS3LGALS4AMY2AAMY1A | |
| Cellobiose SCHEMBL29818287 | 0.82 | LGALS8 (0.53) | LGALS8LGALS3LGALS4AMY2AAMY1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 614 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4392045-A1 | IRON COMPOSITIONS AND METHODS OF MAKING AND USING THEM | American Regent, Inc. (US) | 2024-07-03 | — | — | EP | claimed |
| CN-118085305-A | Production process for controlling size of ferric carboxymaltose nanoparticle and monitoring method thereof | 苏州大学 | 2024-05-28 | — | — | CN | claimed |
| CN-118103047-A | Iron compositions and methods of making and using the same | 美国瑞根特有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117843819-A | Preparation method of ferric carboxymaltose | 金陵药业股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| WO-2024069644-A1 | A PHARMACEUTICALLY ACCEPTABLE FERRIC CARBOXYMALTOSE AND PREPARATION THEREOF | WEST BENGAL CHEMICAL INDUSTRIES LIMITED (IN) | 2024-04-04 | — | — | WO | claimed |
| CN-117756951-A | Iron carboxyl maltose refining process capable of controlling iron carrying amount | 苏州大学 | 2024-03-26 | — | — | CN | claimed |
| US-20240075007-A1 | TREATING IRON DEFICIENCY WITH FERRIC CARBOXYMALTOSE | PHARMACOSMOS HOLDING AS (DK) | 2024-03-07 | — | — | US | claimed |
| US-20240058295-A1 | TREATING IRON DEFICIENCY WITH FERRIC CARBOXYMALTOSE | PHARMACOSMOS HOLDING AS (DK) | 2024-02-22 | — | — | US | claimed |
| CN-115364114-B | Iron carboxyl maltose medicinal composition and preparation method thereof | 武汉科福新药有限责任公司 | 2023-12-01 | — | — | CN | claimed |
| US-11806329-B2 | Treating iron deficiency with ferric carboxymaltose | PHARMACOSMOS HOLDING A/S (DK) | 2023-11-07 | — | — | US | claimed |
| EP-2531097-A1 | METHODS AND DEVICES FOR REDUCING TRANSFUSIONS DURING OR AFTER SURGERY AND FOR IMPROVING QUALITY OF LIFE AND FUNCTION IN CHRONIC DISEASE | Frey, Kathrine P. (US) | 2012-12-12 | — | — | EP | claimed |
| EP-2496595-A2 | PROCESS FOR THE PREPARATION OF IRON (III) CARBOXYMALTOSE COMPLEX | Symed Labs Limited (IN) | 2012-09-12 | — | — | EP | claimed |
| US-20120214986-A1 | PROCESS FOR THE PREPARATION OF IRON (III) CARBOXYMALTOSE COMPLEX | SYMED LABS LIMITED (IN) | 2012-08-23 | — | — | US | claimed |
| WO-2011097313-A1 | METHODS AND DEVICES FOR REDUCING TRANSFUSIONS DURING OR AFTER SURGERY AND FOR IMPROVING QUALITY OF LIFE AND FUNCTION IN CHRONIC DISEASE | FREY KATHRINE P (US) | 2011-08-11 | — | — | WO | claimed |
| WO-2011055374-A2 | PROCESS FOR THE PREPARATION OF IRON (III) CARBOXYMALTOSE COMPLEX | SYMED LABS LIMITED (IN) | 2011-05-12 | — | — | WO | claimed |
| US-20100266644-A1 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | LUITPOLD PHARMACEUTICALS, INC. (US) | 2010-10-21 | — | — | US | claimed |
| US-7754702-B2 | complexed with iron; bioavailability; anemia | LUITPOLD PHARMACEUTICALS, INC. (US) | 2010-07-13 | — | — | US | claimed |
| EP-1973549-A2 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | Luitpold Pharmaceuticals, Inc. (US) | 2008-10-01 | — | — | EP | claimed |
| WO-2007081744-A2 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | LUITPOLD PHARMACEUTICALS, INC. (US) | 2007-07-19 | — | — | WO | claimed |
| US-20070161600-A1 | complexed with iron; bioavailability; anemia | LUITPOLD PHARMACEUTICALS, INC. (US) | 2007-07-12 | — | — | US | claimed |